Health
Johnson & Johnson vaccine: Why it’s worth the minuscule risk – Inverse
The benefits for the one-dose Covid-19 vaccine outweigh the risks.
The CDC and the FDA lifted the pause
on the Johnson & Johnson Covid-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots.
Also, close monitoring of the J&J vaccine along with the Moderna and Pfizer vaccines that were given emergency use authorization will continue.
Dr. William Petri, an infectious disease physician and immunologist at the University of Virginia School of Medicine, explains…
-
Noosa News24 hours agoEaster weather forecast: What to expect in Sydney, Perth, Melbourne, Brisbane, Adelaide and Canberra
-
General24 hours agoAlbanese and Dutton go head-to-head in debate rematch
-
Noosa News24 hours agoQueensland cop cleared by court of stealing watches during anti-gang raid
-
Noosa News14 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn